KRAMPERA, Mauro
 Distribuzione geografica
Continente #
NA - Nord America 10.862
EU - Europa 9.125
AS - Asia 3.530
OC - Oceania 33
SA - Sud America 29
AF - Africa 23
Continente sconosciuto - Info sul continente non disponibili 18
Totale 23.620
Nazione #
US - Stati Uniti d'America 10.802
GB - Regno Unito 3.272
CN - Cina 2.747
IT - Italia 1.258
SE - Svezia 926
FR - Francia 893
IE - Irlanda 868
DE - Germania 723
FI - Finlandia 635
UA - Ucraina 213
SG - Singapore 196
VN - Vietnam 130
BE - Belgio 92
JP - Giappone 89
RU - Federazione Russa 89
KR - Corea 87
IN - India 66
IR - Iran 61
CA - Canada 46
TR - Turchia 38
AU - Australia 31
NL - Olanda 29
HK - Hong Kong 26
ES - Italia 21
AT - Austria 20
MY - Malesia 17
EU - Europa 16
CH - Svizzera 13
RO - Romania 12
EG - Egitto 11
BR - Brasile 10
CL - Cile 9
IL - Israele 9
MX - Messico 9
PL - Polonia 8
BG - Bulgaria 7
IQ - Iraq 7
PT - Portogallo 6
ID - Indonesia 5
LV - Lettonia 5
NO - Norvegia 5
PK - Pakistan 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
CZ - Repubblica Ceca 4
HU - Ungheria 4
KZ - Kazakistan 4
PH - Filippine 4
AR - Argentina 3
CM - Camerun 3
DK - Danimarca 3
LU - Lussemburgo 3
MV - Maldive 3
PA - Panama 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
CI - Costa d'Avorio 2
CO - Colombia 2
CR - Costa Rica 2
CY - Cipro 2
DZ - Algeria 2
GR - Grecia 2
HR - Croazia 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
MA - Marocco 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
PE - Perù 2
QA - Qatar 2
RS - Serbia 2
TH - Thailandia 2
YE - Yemen 2
ZA - Sudafrica 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BO - Bolivia 1
BY - Bielorussia 1
FK - Isole Falkland (Malvinas) 1
IS - Islanda 1
KH - Cambogia 1
LI - Liechtenstein 1
LK - Sri Lanka 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
SM - San Marino 1
Totale 23.620
Città #
Southend 2.973
Jacksonville 1.958
Chandler 1.943
Woodbridge 1.225
Ann Arbor 885
Dublin 862
Houston 664
Ashburn 652
Beijing 407
Jinan 323
Lawrence 316
Princeton 316
Verona 314
Wilmington 307
Shenyang 295
New York 259
Nanjing 257
Hebei 140
Singapore 133
Sindelfingen 132
Tianjin 126
Helsinki 121
Zhengzhou 106
Milan 104
Changsha 98
Nanchang 95
Haikou 90
Brussels 86
Düsseldorf 85
Ningbo 85
Redmond 80
Hangzhou 75
Seoul 72
Dong Ket 70
Taiyuan 66
Jiaxing 65
Taizhou 65
Guangzhou 64
Boardman 62
Lancaster 59
Seattle 59
Norwalk 46
Los Angeles 40
Auburn Hills 38
Fairfield 38
Rome 37
Kent 36
Lanzhou 35
Bologna 32
Dearborn 31
Fuzhou 29
Redwood City 29
San Francisco 28
Falls Church 27
Tokyo 22
Tehran 21
Washington 20
Lappeenranta 19
Chicago 16
Hong Kong 16
Madrid 16
Novosibirsk 15
Frankfurt am Main 14
Kuala Lumpur 13
Melbourne 13
Toronto 13
Vienna 13
Zanjan 13
Xiangfen 12
Clearwater 11
Leawood 11
Paris 11
Parma 11
Amsterdam 10
Dongguan 10
Kochi 10
Palermo 10
Perth 10
Shenzhen 10
Cambridge 9
Edinburgh 9
Elora 9
Florence 9
Napoli 9
Nürnberg 9
Padova 9
Riva 9
Suwon 9
Torino 9
Genova 8
San Diego 8
Shinchiba 8
London 7
Lonigo 7
Mountain View 7
Brescia 6
Cairo 6
Châtenay-Malabry 6
Columbus 6
Lucknow 6
Totale 17.045
Nome #
La citometria a flusso in Ematologia: aspetti tecnici e metodologici 419
Valutazione immunofenotipica della malattia minima residua (MRD) nella leucemia acuta linfoblastica dell'adulto 260
Developmental pathways associated with cancer metastasis: Notch, Wnt, and Hedgehog 174
IFN-gamma- Mediated Upmodulation of MHC Class I Expression Activates Tumor-Specific Immune Response in a Mouse Model of Prostate Cancer 169
IFNalpha-producing bone marrow mesenchymal stem cells (BM-MSCs) contrast tumor growth in a mouse myeloma model. 160
Interferon-alpha-engineered Multipotent Mesenchymal Stromal Cells for the treatment of myeloma 159
Meninges: from protective membrane to stem cell niche 152
Comparative Study of Immune Regulatory Properties of Stem Cells Derived from Different Tissues. 151
Comparison of epithelial differentiation and immune regulatory properties of mesenchymal stromal cells derived from human lung and bone marrow. 149
Analisi del riarrangiamento bcr-abl in alcuni pazienti affetti da leucemia mieloide cronica 148
Caratterizzazione immunofenotipica: principi ed applicazioni in Ematologia 147
Quantitative fluorescence in situ hybridization on paraffin embedded tissue. 147
Identification of microRNAs implicated in the late differentiation stages of normal B cells suggests a central role for miRNA targets ZEB1 and TP53 145
HB-EGF/HER -1 SIGNALLING IN BONE MARROW MESENCHYMAL STEM CELLS: INDUCING CELL EXPANSION AND PREVENTING REVERSIBLY MULTI-LINEAGE DIFFERENTIATION 137
Domanda di brevetto per modello di utilità nr. TO2010U000026 depositata il 23 Febbraio 2010 dal titolo: "DISPOSITIVO PER LA COLTURA CELLULARE", poi convertito in brevetto modello nazionale (nr. 272134) ed internazionale (PCT/IB2011/000365). 132
IN VITRO CHARACTERIZATION OF THE DIFFERENTIATION OF MENINGEAL STEM/PRECURSOR CELLS INTO THE OLIGODENDROCYTE LINEAGE 132
Notch singalling inhibition as a multi-target therapy to overcome bone marrow microenvironment-mediated drug resistance in AML 130
Molecular characterization of msc-derived extracellular vesicles and correlation with their immunomodulatory potential 125
Endothelin B Receptor (Etbr) expression by human malignant plasma cells: preliminary evidence for a role of the endothelin axis in multiple myeloma. 124
Notch signalling drives bone marrow stromal cell-mediated chemoresistance in acute myeloid leukemia 121
Role of GSK-3 signalling in non-promyelocitic acute myeloid leukemia (AML) cell response to chemotherapy 120
In vitro characterization of the differentiation of meningeal Stem/precursor cells into the oligodendrocyte lineage 119
CAL2 Monoclonal Antibody Is a Rapid and Sensitive Assay for the Detection of Calreticulin Mutations in Essential Thrombocythemia and May Provide Prognostic Informations 119
Role of stromal cell-mediated Notch signaling in CLL resistance to chemotherapy 116
Meninges as a niche for stem/precursor cells with neural differentiation potential during development up to adulthood. 116
BCR-ABL fusion transcript b2a2 is associated with a higher risk of non-optimal early response in CP-CML patients treated with standard dose imatinib: a study from Gruppo Triveneto LMC. 116
Acute lymphoblastic leukemia (ALL) in elderly patients receiving intensive treatment. Experience in 26 consecutive patients 115
Migration of meningeal cells in response to contusive spinal cord injury 114
Normal hematopoiesis and hematologic malignancies: role of canonical Wnt signaling pathway and stromal microenvironment 113
Novel stem/progenitor cells with neuronal differentiation potential reside in the leptomeningeal niche 112
Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways 111
In vitro characterization of the differentiation of meningeal stem/precursor cells into the oligodendrocyte lineage 111
Adipose derived mesenchimal stem cells and CNS: differentiation potential and immune suppression 110
The TNF-Family Cytokine TL1A Inhibits Proliferation of Human Activated B Cells 109
Differential and transferable modulatory effects of mesenchymal stromal cell-derived extracellular vesicles on T, B and NK cell functions 108
Inhibition of GSK-3 Signalling Enhances Sensitivity of Non-Promyelocitic Acute Myeloid Leukemia (AML) Cell to Chemotherapy 107
Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis. 106
HUMAN T-LYMPHOBLASTIC LEUKAEMIA CELLS PRODUCE IL-8 IN RESPONSE TOCXCL12 SECRETED BY NORMAL BONE MARROW STROMA 105
Mesenchymal stromal cells (MSCs) induce ex vivo proliferation and erythroid commitment of cord blood haematopoietic stem cells (CB-CD34+ cells) 104
Role of Wnt/β-Catenin Signalling in Acute Myeloid Leukemia (AML) Cell Response to Chemotherapy 104
Adipose-derived stromal cells (ASCs) 103
Espressione del CD30 ligando sulle cellule di differenti neoplasie ematologiche leucemiche 102
Espressione e ruolo funzionale di CD30/CD30L e Fas/FasL in cellule endoteliali umane 102
Serum levels of p55 and p75 soluble TNF receptors in adult acute leukaemia at diagnosis: correlation with clinical and biological features and outcome 102
Adipocytes sustain pancreatic cancer progression through a non-canonical WNT paracrine network inducing ROR2 nuclear shuttling 102
Immunophenotypic approach to the detection of minimal residual disease in acute leukemia 101
Inhibition of Notch signalling overcomes bone marrow stromal-mediated anti-apoptotic and chemoresistance effects in AML. 101
Meninges harbor cells expressing neural precursor markers during development and adulthood 101
CAL2 monoclonal antibody is a rapid and sensitive assay for the detection of calreticulin mutations in essential thrombocythemia and may provide prognostic informations 101
Effective control of acute myeloid leukaemia and acute lymphoblastic leukaemia progression by telomerase specific adoptive T-cell therapy 101
Mesenchymal stem versus stromal cells: International Society for Cell & Gene Therapy (ISCT®) Mesenchymal Stromal Cell committee position statement on nomenclature 101
IN VITRO STUDY OF THE MECHANISMS INVOLVED IN THE BONE MARROW MESENCHY- MAL STROMAL CELL MODULATORY EFFECT ON B CELL FUNCTIONS 100
Predictors of stable deep molecular response in chronic phase chronic myeloid leukemia patients treated with dasatinib or nilotinib after imatinib failure 100
Notch-3 and Notch-4 signaling rescue from apoptosis human B-ALL cells in contact with human bone marrow-derived mesenchymal stromal cells 98
Effects of a Ceramic Biomaterial on Immune Modulatory Properties and Differentiation Potential of Human Mesenchymal Stromal Cells of Different Origin. 98
Expression and role of CD30/CD30L and Fas/FasL in human endothelial cells 97
Mesenchymal stem cells share molecular signature with mesenchymal tumor cells and favor early tumor growth in syngeneic mice 97
Clinical treatment of radiotherapy tissue damages by lipoaspirates transplant: a healing process mediated by adipose-derived adult stem cells (ASCs) 97
IFN-gamma-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancer 97
CXCL12-MEDIATED NF-KAPPAB AND C-JUN ACTIVATION REGULATES INTERLEUKIN 8 PRODUCTION IN HUMAN T-LYMPHOBLASTIC LEUKEMIA 97
Rational of targeting WNT/beta-catenin signaling in acute myeloid leukemia (AML) 97
The puzzling uniqueness of the heterotrimeric G15 protein and its potential beyond hematopoiesis 97
Multipotent stem cell with neural differentiation potential reside in the leptomeninges 96
Homing and Efficacy Assessment of interferon-alpha-engineered mesenchymal stromal cells in a mouse plasmocytoma model 96
A multiplex reverse transcriptase-polymerase chain reaction strategy for the diagnostic molecular screening of chimeric genes: a clinical evaluation on 170 patients with acute lymphoblastic leukemia. 95
METHODOLOGICAL APPROACH TO MINIMAL RESIDUAL DISEASE DETECTION BY FLOW CYTOMETRY IN ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA 95
Immunohistochemical and flow cytometric analysis of the expression of cyclin-dependent kinase 6 (CDK6, PLSTIRE) in cortical thymocytes and T-cell lymphoblastic lymphoma/leukemia 94
Acute Myeloid Leukemia (AML) after BMT in a patient with Acute T-Lymphoblastic Leukemia (T-ALL) in CR, with no detectable minimal residual disease by flow-cytometry 92
Induction of neural-like differentiation in human mesenchymal stem cells derived from bone marrow, fat, spleen and thymus 92
Adult spinal cord meninges: A new source of neural stem cells 92
Efficacy assessment of interferon-alpha-engineered mesenchymal stromal cells in a mouse plasmacytoma model 92
Importance of epigenetic changes in cancer etiology, pathogenesis, clinical profiling, and treatment: What can be learned from hematologic malignancies? 92
Early lymphoid blastic crisis following major karyotypic conversion in a chronic myeloid leukemia patient treated with interferon-a. 91
P21/WAF1 cyclin-kinase inhibitor expression in non-Hodgkin's lymphomas: A potential marker of p53 tumor-suppressor gene function 91
Cytogenetic response to intensive chemotherapy in chronic myelogenous leukemia patients 91
Sequential high dose chemotherapy with PBSC rescue in advanced hematologic malignancies 90
Cellular antigens and soluble molecules and cytokine receptors in leukemia and lymphoma: biological role and clinical applications 90
Early lymphoid blastic crisis following major karyotypic conversion in a chronic myeloid leukemia patient treated with interferon-alpha 90
CHARACTERIZATION OF MESENCHYMAL STROMAL CELL-DERIVED EXTRACELLULAR VESICLES AND CORRELATION WITH THEIR IMMUNOSUPPRESSIVE PROPERTIES TOWARDS B CELLS 90
Serum level of the soluble form of CD30 molecule identifies patients with Hodgkin's disease at high risk of unfavourable outcome. 89
Bone marrow-, spleen- and thymus-derived mesenchymal stem cells favour the growth of myeloma cells in a mouse model 89
Immune Modulation by Mesenchymal Stem Cells 89
Assetto citochinico e pattern del CD30 durante la maturazione del sistema immunitario 88
CD30 e assetto citochinico dei linfociti T, valutato mediante analisi citofluorimetrica, in un caso di sindrome da iper-IgE asintomatica 88
Preventive and therapeutic beneficial effect of adipose-derived mesenchymal stem cells in chronic EAE 88
Circulating levels of soluble CD23 reflect clinical and biological features of leukemic B-cell chronic lymphoproliferative disorders 88
Analysis of HFE and TFR2 gene mutations in patients with acute leukemia. 87
Extracellular Vesicles Mediate Mesenchymal Stromal Cell-Dependent Regulation of B Cell PI3K-AKT Signaling Pathway and Actin Cytoskeleton 87
Impact of allogenic and autologous bone marrow transplantation on acute non-lymphoblastic leukemia treatment: a retrospective study 86
Stem molecular signature of adipose-derived stromal cells. 86
Interferon-alpha-engineered Multipotent Mesenchymal Stromal Cells for the treatment of myeloma 86
In Vitro and In Vivo Model of EBV-Positive Non-Hodgkin Plasmablastic Lymphoma with Focal Plasmacytic Differentiation 86
In Vitro Study Of The Mechanisms Involved In The Bone Marrow Mesenchymal Stromal Cell Modulatory Effect On B Cell Function 86
The impact of P53 and P21(waf1) expression on the survival of patients with the germinal center phenotype of diffuse large B-cell lymphoma 85
Notch signaling in acute lymphoblastic leukemia: any role for stromal microenvironment? 84
Chapter 4: Mesenchymal stem cell isolation and expansion methodology. In: Stem Cells And Cancer Stem Cells: Therapeutic Applications in Disease and Injury 84
A new monoclonal antibody detects downregulation of protein tyrosine phosphatase receptor type γ in chronic myeloid leukemia patients 84
Bone marrow-derived stromal cells inhibit spontaneous apoptosis and induce proliferation in blasts of T acute lymphoblastic leukaemia: the role of interleukin 7 83
HB-EGF/HER-1 signaling in bone marrow mesenchymal stem cells: inducing cell expansion and reversibly preventing multilineage differentiation 83
Serum- and stroma-free in vitro culture of primary B-CLL cells 83
Totale 11.086
Categoria #
all - tutte 72.261
article - articoli 38.420
book - libri 0
conference - conferenze 32.325
curatela - curatele 0
other - altro 238
patent - brevetti 284
selected - selezionate 0
volume - volumi 994
Totale 144.522


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019115 0 0 0 0 0 0 0 0 0 0 0 115
2019/20202.767 318 41 32 261 200 407 167 267 207 324 140 403
2020/20212.945 208 426 191 387 339 351 47 218 203 32 358 185
2021/20222.624 304 707 38 178 120 54 32 155 102 93 234 607
2022/20235.552 407 569 513 1.054 460 1.349 30 332 572 50 136 80
2023/20242.890 114 213 258 307 344 502 191 180 33 210 482 56
Totale 23.996